The therapeutic validation of long COVID
- PMID: 37302405
- PMCID: PMC10250006
- DOI: 10.1016/S1473-3099(23)00355-9
The therapeutic validation of long COVID
Conflict of interest statement
I declare no competing interests.
Comment on
-
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial.Lancet Infect Dis. 2023 Oct;23(10):1119-1129. doi: 10.1016/S1473-3099(23)00299-2. Epub 2023 Jun 8. Lancet Infect Dis. 2023. PMID: 37302406 Free PMC article. Clinical Trial.
References
-
- Bramante CT, Buse JB, Liebovitz DM, et al. Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial. Lancet Infect Dis. 2023 doi: 10.1016/S1473-3099(23)00299-2. published online June 8. - DOI - PMC - PubMed
-
- US Centers for Disease Control and Prevention Post-COVID conditions. Dec 16, 2022. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html
-
- WHO Post COVID-19 condition (long COVID) 2023. https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-cond...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical